1399176-01-2

Basic information

• Product Name: 4-(1-(5-(6-((2-methoxyethyl)(methyl)amino)-3H-imidazo[4,5-c]pyridin-2-yl)-2,4-dimethylbenzoyl)piperidin-4-yl)benzonitrile trifluoroacetate
• Synonyms: 4-(1-(5-(6-((2-methoxyethyl)(methyl)amino)-3H-imidazo[4,5-c]pyridin-2-yl)-2,4-dimethylbenzoyl)piperidin-4-yl)benzonitrile trifluoroacetate
• CAS NO: 1399176-01-2
• Molecular Weight: 636.674
• Mol File: 1399176-01-2.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 4-(1-(5-(6-((2-methoxyethyl)(methyl)amino)-3H-imidazo[4,5-c]pyridin-2-yl)-2,4-dimethylbenzoyl)piperidin-4-yl)benzonitrile trifluoroacetate(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(1-(5-(6-((2-methoxyethyl)(methyl)amino)-3H-imidazo[4,5-c]pyridin-2-yl)-2,4-dimethylbenzoyl)piperidin-4-yl)benzonitrile trifluoroacetate(1399176-01-2)
• EPA Substance Registry System: 4-(1-(5-(6-((2-methoxyethyl)(methyl)amino)-3H-imidazo[4,5-c]pyridin-2-yl)-2,4-dimethylbenzoyl)piperidin-4-yl)benzonitrile trifluoroacetate(1399176-01-2)

Safety Data

• Hazardous Substances Data: 1399176-01-2(Hazardous Substances Data)

Upstream product

• 611-01-8 2,4-dimethyl-benzoic acid 
• 162997-34-4 4-(piperidin-4-yl)benzonitrile hydrochloride 
• 162997-33-3 tert-butyl 4-(4-cyanophenyl)piperidine-1-carboxylate 
• 460365-08-6 4-(4-cyanophenyl)-3,6-dihydro-2H-pyridine-1-carboxylic acid tert-butyl ester 
• 871112-38-8 tert-butyl 4-(4-cyanophenyl)-4-hydroxypiperidine-1-carboxylate 
• 163209-96-9 tert-butyl 4-(4-bromophenyl)-4-hydroxypiperidine-1-carboxylate 
• 79099-07-3 N-tert-butyloxycarbonylpiperidin-4-one 
• 589-87-7 1,4-bromoiodobenzene 
• 1399181-26-0 N²-(2-methoxyethyl)-N²-methylpyridine-2,4,5-triamine 
• 1399181-27-1 4-(1-(5-formyl-2,4-dimethylbenzoyl)piperidin-4-yl)benzonitrile 
• 76-05-1 trifluoroacetic acid 
• 742081-03-4 5-iodo-2,4-dimethylbenzoic acid 

Relevant articles and documents

Imidazopyridine-based fatty acid synthase inhibitors that show anti-HCV activity and in vivo target modulation

Potent imidazopyridine-based inhibitors of fatty acid synthase (FASN) are described. The compounds are shown to have antiviral (HCV replicon) activities that track with their biochemical activities. The most potent analogue (compound 19) also inhibits rat FASN and inhibits de novo palmitate synthesis in vitro (cell-based) as well as in vivo.